Skip to main content

Find Clinical Trials

Home
Conditions
Hyperparathyroidism

Clinical trial condition

Hyperparathyroidism

Explore clinical trials studying Hyperparathyroidism. Study availability and eligibility vary by location and protocol.

234 public trials 29 recruiting studies

Refine in advanced search Browse all conditions

Hyperparathyroidism trial results

Completed

A Multicenter, Open-label Extension Study to Assess the Long-term Safety and Efficacy of an Oral Calcimimetic Agent AMG 073 (Cinacalcet) in Primary Hyperparathyroidism

NCT00936988

Conditions: Endocrine System Diseases, Hyperparathyroidism, Hyperparathyroidism, Primary, +1 more
Locations: Not specified

View Trial Details

Completed

A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Patients on Dialysis

NCT00042653

Conditions: Chronic Disease, Disease Attributes, End Stage Renal Disease, +16 more
Locations: Not specified

View Trial Details

Completed

A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Dialysis Patients

NCT00037635

Conditions: Chronic Disease, Disease Attributes, End Stage Renal Disease, +16 more
Locations: Not specified

View Trial Details

Completed

A Study to Assess the Efficacy and Safety of Twice-Daily Dose Regimens of an Oral Calcimimetic Agent AMG 073 (Cinacalcet) in Primary Hyperparathyroidism (PHPT)

NCT00936650

Conditions: Endocrine System Diseases, Hyperparathyroidism, Hyperparathyroidism, Primary, +1 more
Locations: Not specified

View Trial Details

Completed

A Study of Cinacalcet to Improve Achievement of National Kidney Foundation Kidney Disease Outcomes Quality Initiative (K/DOQI) Targets in Patients With End Stage Renal Disease (ESRD)

NCT00431496

Conditions: Anemia, Endocrine System Diseases, Hematologic Diseases, +5 more
Locations: Not specified

View Trial Details

Completed

Paricalcitol Oral Therapy in Predialysis CKD Patients. The Greek Experience

NCT01083186

Conditions: Chronic Disease, Chronic Kidney Failure, Disease Attributes, +16 more
Locations: Site Reference ID/Investigator# 47002 Arta, Greece

Site Reference ID/Investigator# 43772 Athens, Greece

Site Reference ID/Investigator# 27492 Athens, Greece

Site Reference ID/Investigator# 43769 Athens, Greece

View all 24 locations

View Trial Details

Completed

Paricalcitol in Reducing Parathyroid Hormone Levels and Ameliorating Markers of Bone Remodelling in Renal Transplant Recipients With Secondary Hyperparathyroidism

NCT01220050

Conditions: Endocrine System Diseases, Hyperparathyroidism, Hyperparathyroidism, Secondary, +3 more
Locations: Mario Negri Institute - Clinical Research Center for Rare Diseases Ranica, Bergamo, Italy

View Trial Details

Completed

Evaluation of Non Specific Symptoms and Quality of Life Before and After Surgery for Mild Primary Hyperparathyroidism

NCT01776502

Conditions: Endocrine System Diseases, Hyperparathyroidism, Hyperparathyroidism, Primary, +2 more
Locations: Angers University Hospital Angers, France

Limoges University Hospital Limoges, France

Marseille University Hospital Marseille, France

Nantes University Hospital Nantes, France

View Trial Details

Completed

Morbidity Related to Secondary Hyperparathyroidism After Renal Transplantation

NCT01741064

Conditions: Cardiovascular Diseases, Disorder Related to Renal Transplantation, Endocrine System Diseases, +15 more
Locations: Not specified

View Trial Details

Completed

A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD

NCT00785629

Conditions: Calcinosis, Calcium Metabolism Disorders, Chronic Disease, +19 more
Locations: Denver Nephrologists, PC Denver, Colorado, United States

View Trial Details